傳染病診斷市場 是由出版商Kalorama Information在2009年08月所出版的。
這份英文市場調查報告書包含180 pages 價格從美金3500起跳。
本報告書內容包括：用於細菌・病毒傳染診斷的產品介紹、市場規模及未來預測、傳染病診斷市場未來10年的長期預測、主要產品概要、市場競爭等。內容綱要摘記如下：
第1章 實施概要
第2章 傳染病概要
- 全般
- 傳染
- 主要病原體
- 動物原性傳染病
- 伺機性傳染病原體
- 易傳染度
- 細菌傳染
- 病毒傳染
- 新型流感及IVD產業
- 流感病毒的來源
- PCR檢查的發展
- 研究開發
- 現在流行病學中即時檢查之利用
第3章 技術及產品
- 細菌培養
- 血液培養
- 咽喉培養
- 痰培養
- 骨髓培養
- 大便培養
- 尿培養
- 病毒培養
- 免疫檢查
- 分子診斷
- 增幅技術
第4章 傳染病診斷市場
- 非傳統系統之利用增加
- 市場分析
- 鎖定微生物及抗微生物感受性檢查
- 即時檢查
- 免疫檢查：實驗室基礎
- STD
- 用品
- 競爭
- 主要企業動向
- AdvanDx
- Beckman Coulter
- bioMerieux
- BioRad
- Cepheid
- Gen-Probe
- Roche Molecular Diagnostics
- Siemens Healthcare Diagnostics
第5章 結論及策略影響
專有名詞
圖表
Abstract
The ubiquity of infections makes thier detection a healthcare priority and an
ongoing opportunity for IVD companies. The aging of the population, and
emerging threats - MRSA, swine flu, and others have had an impact on this
market recently and will continue to in years to come. Kalorama Information
has been observing diagnostic markets for over a decade and has assembled in
this report, Infectious Disease Diagnostics, Kalorama Information has
assembled its best primary and secondary research.
This report focuses on products used for the diagnosis of bacterial and viral
infections. The major consideration is given to bacterial infections because
(a) they are the most frequent type of infections, and (b) the practical
aspects of diagnosis and therapy are more meaningful based both on medial
considerations and on market considerations. On the other hand, viral
infections are becoming of greater importance due to (a) the discovery of new
viral infections, (b) advances in the development of viral therapeutics, and
(c) the mutation viruses that cause drug resistance.
Included in this report:
- Market Size and Forecast for (Immunoassays, Rapid, DNA, ID/MIC )
- Overview of Key Infections and Their Impact on the Market
- Long-Term (10 Year) Trend in the Infectious Disease Diagnostics
Market
- Seven Conclusions and Recommendations
- Key Product Summary: Immunoassay Products, Molecular Diagnostic
Products, Amplification Products
- Discussion and Listing of ‘Home Brew' Products
- Discussion of Leading Competitors in the Market
- Increasing Use of Non Traditional Technologies in ID (FISH, Flow
Cytometry, etc.)
- The Role of NAT Testing Near-Term and Long-Term
- A Glossary of Important Terms
- Best Opportunities for IVD Companies
Market analysis in this report considers primarily the epidemiological
considerations and the sizes patient groups both in the United States and
globally, where available. We have accumulated the most recent data available,
understanding that virtually no organization does extensive studies on these
applications on a regular basis.
As with most Kalorama reports, this is a work of both market description and
analysis, along with recommendations. The analysis presented in this report is
based on data from a combination of company, government, industry,
institutional and private sources. It includes information from extensive
literature reviews and discussions with experts in the field, including
microbiologists, pathologists, hospital authorities, research scientists,
business development managers and marketing managers.
In this report global (world) revenue numbers are presented based on reported
and estimated manufacturer revenue.
Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
- Overview
- Scope and Methodology
- Market Considerations
- Trends Affecting Infectious Disease Diagnosis Applications
- Opportunity for Diagnostic Products in Infectious Disease
- Drug Resistance
- Have Immunoassays Peaked?
- Need for Faster Tests
- “Controlled Growth” of NAT
- Drug Susceptibility and Resistance Testing Markets
- A Need for Simplification
CHAPTER TWO: OVERVIEW OF INFECTIOUS DISEASES
- General
- Infectivity
- Primary Pathogens
- Zoonoses
- Opportunistic Pathogens
- Disease Susceptibility
- Bacterial Infections
- Viral Infections
- Swine Flu and the IVD Industry
- Origin of Flu Virus Mixes
- PCR Test Development
- Late-Breaking Research Developments
- Use of Rapid Tests in Current Epidemic
CHAPTER THREE: TECHNOLOGY AND PRODUCTS
- Bacterial Cultures: Diagnosis and Susceptibility
- Blood Culture
- Throat Culture
- Sputum Cultures
- Spinal Fluid Cultures
- Stool Cultures
- Urine Cultures
- Viral Culture
- Immunoassays
- Agglutination Immunoassays
- Nephelometry
- Indirect Immunofluorescence
- Enzyme Immunoassay (ELISA, EIA)
- Fluorescence and Luminescence Immunoassay
- Magnetic Immunoassay
- Molecular Diagnostics
- Amplification Technologies
CHAPTER FOUR: INFECTIOUS DISEASE DIAGNOSTICS MARKETS
- Increasing Use of Non-Traditional Systems
- FISH
- Cell Counting by Flow Cytometry
- Laser Based Microbial Detection
- Market Analysis
- Microbial Identification and Antimicrobial Sensitivity Tests
- Rapid Tests
- Immunoassays - Lab based
- STDs
- Supplies
- Competition
- Key Company Synopses
- AdvanDx
- Beckman Coulter
- bioMerieux
- BioRad -
- Cepheid -
- Gen-Probe
- Roche Molecular Diagnostics
- Siemens Healthcare Diagnostics -
CHAPTER FIVE: CONCLUSIONS AND STRATEGIC IMPLICATIONS
- First Conclusion
- Second Conclusion
- Third Conclusion
- Fourth Conclusion
- Fifth Conclusion
- Sixth Conclusion
- Seventh Conclusion
GLOSSARY
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY:
- Figure 1-1: Worldwide Infectious Disease Diagnostics Sales
- Figure 1-2: Trend in Revenue in Infectious Disease Diagnostics Long-Term
(NAT, Rapid, Immunoassays)
CHAPTER TWO: OVERVIEW OF INFECTIOUS DISEASES
- Table 2-1: Classification of Common Pathogenic Bacteria
- Table 2-2: Common Mechanisms of Antibacterial Resistance
CHAPTER THREE: TECHNOLOGY AND PRODUCTS
- Table 3-1: Key Immunoassay Products Used for Clinical Testing for
Bacterial Infections
- Table 3-2: Molecular Diagnostics Technologies
- Table 3-3: Gene Amplification Technologies
- Table 3-4: Commonly Used Signal Amplification Technologies for Genetic
Analysis
- Table 3-5: Key Molecular Assay Products for the Diagnosis of Infectious
Diseases (Company, Analyte, Test Category, Product, Technology)
- Table 3-6: Key “Home Brew” Molecular Assays for Infectious
Diseases
CHAPTER FOUR: INFECTIOUS DISEASE DIAGNOSTICS MARKETS
- Table 4-1: Companies Engaged in the Market for Bacterial Culture Products
- Table 4-1: PCR, FISH, Flow and Cell Imaging Systems for Bacteria / Virus
Detection, 2008 and 2012 ($million)
- Table 4-2: Worldwide Microbiology/Virology Sales by Type (Immunoassays,
Rapid, DNA, ID/MIC ) 2008-2013
- Table 4-3 : ID/MIC Revenue Breakdown (Automated Panels and Reagents,
Manual Panels and Reagents, Blood Culture, Rapid Micro) and Supplies
- Table 4-4: Selected Chromogenic Growth Media (Company, Location, Media)
|
